Searched for: in-biosketch:true
person:goldea01
Chemoembolization (CE) with radio-frequency ablation (RFA) in metastatic tumors of the liver [Meeting Abstract]
Amsterdam A; Schlossberg P; Goldenberg A; Oratz R
ORIGINAL:0006500
ISSN: 0736-7589
CID: 92761
Transplantation for hepatocellular carcinoma and cirrhosis: sensitivity of magnetic resonance imaging
Krinsky, Glenn A; Lee, Vivian S; Theise, Neil D; Weinreb, Jeffrey C; Morgan, Glyn R; Diflo, Thomas; John, Devon; Teperman, Lewis W; Goldenberg, A S
The sensitivity of magnetic resonance imaging (MRI) in patients who undergo transplantation for hepatocellular carcinoma (HCC) and cirrhosis is not known. We prospectively evaluated 24 patients with known HCC who underwent MRI and subsequent transplantation within 60 days (mean, 20 days). Using a phased-array coil at 1.5T, breath-hold turbo STIR and T2-weighted MR images were performed. Dynamic gadolinium-enhanced MRI was performed using a two- or three-dimensional gradient echo pulse sequence with images obtained in the hepatic arterial, portal venous, and equilibrium phases. The prospective interpretation of the MR study was directly compared with thin-section pathology evaluation of the explanted livers. All 24 patients had at least one HCC, and MR diagnosed tumor in 21 (88%) of these patients. On a lesion-by-lesion basis, MRI depicted 39 of 118 HCC for an overall sensitivity of 33%. MRI detected five (100%) of five lesions >5 cm, 20 (100%) of 20 lesions >2 cm but not exceeding 5 cm, 11 (52%) of 21 lesions between 1 and 2 cm, and three (4%) of 72 lesions <1 cm. Of the nine patients with carcinomatosis (innumerable lesions less than 1 cm), MR detected three lesions in one patient. Of the 15 dysplastic nodules found at pathology, MRI depicted a single 1.8-cm high-grade lesion, for a sensitivity of 7%. In conclusion, MRI is sensitive for the detection of HCC measuring at least 2 cm in diameter but is insensitive for the diagnosis of small HCC (<2 cm) and carcinomatosis
PMID: 12474156
ISSN: 1527-6465
CID: 92764
Clinical experience with a new specimen capturing bone marrow biopsy needle
Goldenberg AS; Tiesinga JJ
The SNARECOIL needle is a specimen capturing bone marrow biopsy needle that incorporates a tiny internal capturing coil. It was developed to minimize postinsertion needle manipulation and to facilitate specimen recovery. Forty-four patients underwent 50 bone marrow biopsy procedures with the SNARECOIL needle for a variety of hematologic indications. Second and third procedures were done for follow-up or staging. Each procedure retrieved a specimen with an average length of 2.1 cm. Fifty-two percent of the specimens were > or =2.0 cm in length. The majority of specimens demonstrated intact marrow architecture enabling a pathologic diagnosis in every case. Delicate cores of nontrabeculated marrow were recovered in three cases. The SNARECOIL bone marrow biopsy needle reliably retrieves intact bone marrow core specimens for pathologic interpretation
PMID: 11754401
ISSN: 0361-8609
CID: 26540
Chemoembolization for Hepatocellular Carcinoma
Goldenberg A; Teperman L; Rosen R
ORIGINAL:0006503
ISSN: n/a
CID: 92765
MEIS1 and HOXA7 genes in human acute myeloid leukemia
Afonja O; Smith JE; Cheng DM; Goldenberg AS; Amorosi E; Shimamoto T; Nakamura S; Ohyashiki K; Ohyashiki J; Toyama K; Takeshita K
Co-activation of Meisl with Hoxa7 or Hoxa9 homeobox genes by retroviral gene insertion has recently been reported to be leukemogenic in murine myeloid leukemia. In this study we determined their expression in human leukemia. Most human myeloid leukemia cell lines co-expressed MEIS1 with HOXA7 and HOXA9. Among patients with acute leukemia, 50% of AML patients expressed MEIS1, while the majority of ALL patients were negative. A total of 89.5% of patients expressing MEIS1 co-expressed HOXA7. In unadjusted models, poorer response to chemotherapy was associated with expression of HOXA7 regardless of MEIS1 status and older patients were more likely to express either gene
PMID: 10996203
ISSN: 0145-2126
CID: 17839
Plasmacytoma of the breast. A report of two cases diagnosed by aspiration biopsy [Case Report]
Cangiarella J; Waisman J; Cohen JM; Chhieng D; Symmans WF; Goldenberg A
BACKGROUND: Extramedullary plasmacytoma of the breast is an uncommon neoplasm, occurring either as a solitary tumor or as evidence of disseminated multiple myeloma. CASE: Two cases of plasmacytoma of the breast were diagnosed by fine needle aspiration cytology. Aspiration smears showed a dispersed population of plasmacytoid cells with eccentric nuclei, abundant cytoplasm and the characteristic paranuclear hof. CONCLUSION: The clinical, cytologic and immunophenotypic features of plasmacytoma are characteristic, and the importance of distinguishing these neoplasms from primary mammary tumors is important to avoid unnecessary surgery
PMID: 10667168
ISSN: 0001-5547
CID: 11840
Dysplastic nodules and hepatocellular carcinoma: sensitivity of digital subtraction hepatic arteriography with whole liver explant correlation
Krinsky GA; Nguyen MT; Lee VS; Rosen RJ; Goldenberg A; Theise ND; Morgan G; Rofsky NM
PURPOSE: The purpose of this work was to determine the sensitivity of hepatic digital subtraction arteriography (DSA) for the detection of hepatocellular carcinoma (HCC) and dysplastic nodules (DNs) when compared with pathological findings from whole liver explants. METHOD: Twenty-one patients 30-72 years old (mean 54 years) with cirrhosis and known or clinically suspected HCC (20 prior to chemoembolization) underwent hepatic DSA with subsequent transplantation within 80 days (mean 32 days). The prospective DSA report was compared with pathologic findings from explanted livers. RESULTS: Overall, DSA detected 31 of 95 HCC lesions for a sensitivity of 33%. Of these 31 lesions, 28 were hypervascular and 3 were hypovascular. DSA detected all six HCCs measuring >5 cm, all six HCCs measuring 3-5 cm, and all five HCCs 2-3 cm, resulting in a sensitivity of 100% (17/17) for HCC >2 cm. DSA detected 7 of 18 HCCs measuring 1-2 cm (sensitivity 39%) and 7 of 60 HCCs < or =1 cm (sensitivity 12%). Overall sensitivity for DSA in detection of HCC < or =2 cm was 18% (14/78 lesions). None of 17 DNs (0.2-1.5 cm in size) was identified on DSA. CONCLUSION: DSA is insensitive to small HCC (< or =2 cm), carcinomatosis arising within nodules, and DN
PMID: 10966200
ISSN: 0363-8715
CID: 11521
Clinical experience with the Snarecoil (TM) (SC) bone marrow (BM) biopsy (Bx) needle (N) [Meeting Abstract]
Goldenberg, AS; Tiesinga, JJ
ISI:000165256201785
ISSN: 0006-4971
CID: 55225
Chemoembolization-induced tumor necrosis: Correlation of HRI. Pathology and clinical outcome in cirrhotics with hepatocellular carcinoma [Meeting Abstract]
Morgan, GR; Goldenberg, A; Rosen, R; Rofsky, N; Mizrahi, H; Thiese, N; Diflo, T; Devon, J; Teperman, L
ISI:000080624100364
ISSN: 0041-1337
CID: 92754
Bone-marrow biopsy needle incorporating a snare-coil specimen-capturing device: description and preclinical studies
Goldenberg, A S; Rishton, M
A tissue biopsy needle maximizes adequate specimen retrieval and minimizes patient pain and tissue disruption. The proposed biopsy needle incorporates an internal snare-coil for capturing specimens. The snare-coil device is described along with needle durability and performance testing. Sharply cut, nonfragmented, cored specimens were retrieved from a resin-based foam. In clinical practice, the snare-coil technology may minimize post-insertion needle manipulations and patient pain. Further studies are required to determine the impact of snare-coil needles on the retrieval of adequate specimens from patients
PMID: 10626043
ISSN: 0899-8205
CID: 92740